Baidu
map

DIABETES CARE:糖尿病患者冠脉狭窄风险明显升高

2013-03-07 晓东 编译 医学论坛网

    一项最新研究显示,我国早期糖尿病患者中无心肌缺血症状者,其发生冠脉狭窄的风险明显升高。血糖水平是糖尿病患者发生冠脉狭窄的独立危险因素。研究由上海交通大学医学院附属瑞金医院宁光等人进行,2013年3月5日在线发表于《糖尿病护理》(Diabetes Care)杂志。   研究旨在评价无心肌缺血症状的中国成年糖尿病患者或糖尿病前期人群的冠脉狭窄风险。研究者从社

糖尿病患者冠脉狭窄风险明显升高
 

  一项最新研究显示,我国早期糖尿病患者中无心肌缺血症状者,其发生冠脉狭窄的风险明显升高。血糖水平是糖尿病患者发生冠脉狭窄的独立危险因素。研究由上海交通大学医学院附属瑞金医院宁光等人进行,2013年3月5日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  研究旨在评价无心肌缺血症状的中国成年糖尿病患者或糖尿病前期人群的冠脉狭窄风险。研究者从社区居民中随机选取年龄40-60岁的糖调节正常(NGR)、糖尿病前期或5年内确诊糖尿病者,进行双源CT冠脉血管造影并评估其冠脉狭窄发生情况及狭窄程度,所有受试者均无心肌缺血症状。严重狭窄定义为管腔狭窄程度大于50%。

  经排除不可解释的可归因于运动伪影(motion artifacts)因素,NGR组135名受试者、糖尿病组132名受试者与糖尿病前期组134名受试者纳入数据分析。三组中发生冠脉严重狭窄者分别为10人(7.4%)、10人(7.6%)和22人(16.4%)(P=0.029)。与NGR组受试者相比,糖尿病(而非糖尿病前期)组患者发生冠脉严重狭窄的风险显著升高2.34倍[比值比2.34,(95%可信区间1.01–5.43);P = 0.047]。

  血糖水平是糖尿病患者发生冠脉狭窄的独立与显著危险因素。校正其他传统心血管危险因素后,空腹血糖、餐后两小时血糖与糖化血红蛋白(HbA1c)每升高一个标准单位,冠脉严重狭窄发生风险分别增加2.11倍、1.73倍和1.81倍。

糖尿病相关的拓展阅读:


Significant Coronary Stenosis in Asymptomatic Chinese With Different Glycemic Status

OBJECTIVE 

To evaluate coronary artery stenosis in early diabetes or prediabetes asymptomatic of myocardial ischemia in community-dwelling Chinese adults.

RESEARCH DESIGN AND METHODS 

Age- and sex-matched participants with normal glucose regulation (NGR), prediabetes, or diabetes diagnosed within 5 years, asymptomatic of coronary artery disease (CAD), were randomly selected from a community-dwelling Chinese population aged 40–60 years. Dual-source computed tomography coronary angiography was used to evaluate the existence and extent of coronary stenosis, which was considered significant if >50% narrowing of vessel lumen was detected.

RESULTS 

After excluding uninterpretable segments attributable to motion artifacts, a total of 135 participants with NGR, 132 with prediabetes, and 134 with diabetes participated in data analysis. Significant coronary stenosis was detected in 10 (7.4%), 10 (7.6%), and 22 (16.4%) individuals with NGR, prediabetes, and diabetes, respectively (P for trend = 0.029). Diabetes, rather than prediabetes, was associated with a significant 2.34-fold elevated risk [odds ratio (OR) 2.34 (95% CI 1.01–5.43); P = 0.047] of significant coronary stenosis as compared with that associated with NGR. Levels of glucose evaluation were independently and significantly associated with risks of significant coronary stenosis in diabetes. Each 1-SD increase in fasting plasma glucose, 2-h postload plasma glucose, and HbA1c conveyed 2.11-fold, 1.73-fold, and 1.81-fold higher risks of significant coronary stenosis, respectively, after adjustment for other conventional cardiovascular risk factors.

CONCLUSIONS 

Using a noninvasive CAD diagnostic modality such as dual-source computed tomography coronary angiography, we detected a markedly elevated risk of significant coronary stenosis with early diabetes in asymptomatic Chinese adults.


  

    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]
    2016-07-23 午夜星河

    嗯嗯嗯,看看文章

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]
    2015-07-02 owlhealth

    多学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=94293, encodeId=a46a94293c9, content=嗯嗯嗯,看看文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sat Jul 23 14:09:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30212, encodeId=74ae302127f, content=多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Jul 02 12:52:00 CST 2015, time=2015-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901054, encodeId=a19d190105428, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Apr 07 05:56:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778534, encodeId=8bcb1e7853461, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jun 27 06:56:00 CST 2013, time=2013-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636630, encodeId=d592163663049, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Jun 10 03:56:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759247, encodeId=4ad61e5924733, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Mar 21 11:56:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473689, encodeId=c52f14e368947, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Mar 09 07:56:00 CST 2013, time=2013-03-09, status=1, ipAttribution=)]

相关资讯

Diabetes Care:LOGIC-Insulin算法指导强化血糖控制效果佳

  来自荷兰鲁汶大学的一项前瞻性、平行组、随机对照临床试验显示,应用计算机软件程序LOGIC-Insulin实施强化血糖控制(TGC)的效能优于经验丰富的护士,且不增加低血糖事件的发生率。该研究2013年2月在线发表在《糖尿病护理》杂志(Diabetes care)上。   对危重患者实施TGC较为困难,且工作强度大,导致血糖控制效果不佳和低血糖发生率增加。LOGIC-Insul

Diabetes Care:经皮氧分压可预测糖尿病患者心血管风险

  意大利学者进行的一项研究提示,经皮氧分压(TcPO2)是无合并症2型糖尿病患者主要不良心脏事件(MACE)风险的潜在预测指标,且预测价值似乎高于踝臂指数(ABI)。研究于2013年2月12日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究入选361例无合并症的2型糖尿病患者,随访45.8个月期间共发生67例MACE。研究者报告,发生MACE的受试者中ABI(≤0.9)

JGIM:血糖达标非糖尿病患者心血管获益关键

  一项纳入2.6万余例受试者的观察性研究显示,对于2型糖尿病患者,收缩压(SBP,<130 mm Hg)或低密度脂蛋白胆固醇(LDL-C,<100 mg/dl)达标与心血管疾病(CVD)住院风险的降低显著相关,而糖化血红蛋白(HbA1c)达标(<7%)并不是CVD住院风险降低的独立因素。(J Gen Intern Me

PLOS ONE:强化降糖或使肥胖糖尿病患者获益

  一项覆盖9项随机对照研究、59 197例受试者的Meta分析提示,对于体质指数(BMI)>30 kg/m2的糖尿病患者,与标准降糖方案相比,强化降糖方案可有效降低卒中发生风险。(PLoS One. 2013,8:e54465)   在被纳入的59 197例受试者中,2037例罹患卒中。分析结果显示,在整个受试人群中,与标准降糖方案相比,

Diabetes Care:美国糖尿病患者“三达标率”较高

  美国学者Sarah Stark Casagrande等报告,2007-2010年间有18.8%的美国糖尿病患者糖化血红蛋白(HbA1c)、血压和低密度脂蛋白胆固醇(LDL-C)水平同时达标,达标率是我国糖尿病患者(5.6%)的3倍以上。研究于2013年2月15日在线发表于《糖尿病护理》(Diabetes Care)杂志。   研究者利用1988-2010年美国国

Diabetes Care:空气污染诱发糖尿病患者炎症反应

  《糖尿病护理》杂志日前发表伊朗和印度科学家合作完成的一项新研究[Diabetes Care. 2013 Mar;36(3):625-30]称,空气污染可能诱发2型糖尿病患者全身性炎症反应,增加其发生血管并发症的风险。   血浆C-反应蛋白(CRP)水平与胰岛素抵抗、糖尿病及其并发症呈现相关性,血浆CRP水平下降有助于降低胰岛素抵抗、糖尿病并发症发生风险。伊朗让迪

Baidu
map
Baidu
map
Baidu
map